US Bioservices, AdhereTech partner to improve patient adherence
US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, announced findings from an initial program with AdhereTech. Based on the program’s successful results, US Bioservices plans to extend the AdhereTech offering to larger patient populations by including the Smart Pill Bottle in additional manufacturer programs.
A provider of pharma-sponsored support programs for specialty medications, AdhereTech develops patented Smart Pill Bottles for manufacturers and pharmacies across the U.S. AdhereTech collaborated with US Bioservices to analyze 18 months of fill-level data for patients using the Smart Pill Bottles for their medications. The results showed that patients new to therapy who began treatment with the Smart Pill Bottle stayed on therapy for 1.5 additional months and had 1.3 additional fills dispensed. Consistently, patients continuing on a therapy had 1.2 additional fills dispensed compared to their peers not in the program.
“US Bioservices is committed to providing our patients with the highest level of support so that they can achieve the best results from their therapies. We know that adherence remains one of the most critical challenges facing patients, and we are excited to expand access to a data-backed solution that is directly correlated to more positive outcomes,” US Bioservices president Angela Ward said. “This new offering is aligned with our commitment to pushing the frontier of support solutions to maximize benefits for patients, manufacturers and providers alike.”
The AdhereTech Smart Pill Bottle is simple and seamless for patients to use, requiring no additional costs or set up, the company said.
The system analyzes data and sends personalized messages to patients about missed doses and upcoming refill reminders, via text message or phone call. AdhereTech’s capabilities also include notifying a patient’s pharmacy in real-time if the patient encounters a health or medication issue, enabling pharmacist intervention sooner.
A provider of pharma-sponsored support programs for specialty medications, AdhereTech develops patented Smart Pill Bottles for manufacturers and pharmacies across the U.S. AdhereTech collaborated with US Bioservices to analyze 18 months of fill-level data for patients using the Smart Pill Bottles for their medications. The results showed that patients new to therapy who began treatment with the Smart Pill Bottle stayed on therapy for 1.5 additional months and had 1.3 additional fills dispensed. Consistently, patients continuing on a therapy had 1.2 additional fills dispensed compared to their peers not in the program.
“US Bioservices is committed to providing our patients with the highest level of support so that they can achieve the best results from their therapies. We know that adherence remains one of the most critical challenges facing patients, and we are excited to expand access to a data-backed solution that is directly correlated to more positive outcomes,” US Bioservices president Angela Ward said. “This new offering is aligned with our commitment to pushing the frontier of support solutions to maximize benefits for patients, manufacturers and providers alike.”
The AdhereTech Smart Pill Bottle is simple and seamless for patients to use, requiring no additional costs or set up, the company said.
The system analyzes data and sends personalized messages to patients about missed doses and upcoming refill reminders, via text message or phone call. AdhereTech’s capabilities also include notifying a patient’s pharmacy in real-time if the patient encounters a health or medication issue, enabling pharmacist intervention sooner.